| |
| |
|
| Insider
Information: |
Tastad Carolyn M |
| Relationship: |
Director |
| City: |
Cincinnati |
| State: |
OH |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
28,156 |
|
|
Indirect Shares
|
30,414 |
|
|
| Direct
Value |
$4,595,059 |
|
|
|
Indirect Value
|
$2,660,095 |
|
|
| Total
Shares |
58,570 |
|
|
| Total
Value |
$7,255,154 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
14
|
|
Stock
price went up :
|
0
|
11
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.7
|
| Percentage
Gain/Loss : |
0.0%
|
 132.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Procter & Gamble Co |
PG |
CEO - Health Care |
2022-03-01 |
28,156 |
2022-03-01 |
8,547 |
Premium* |
|
|
Kellanova |
K |
Director |
2016-05-09 |
0 |
2023-05-08 |
21,867 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| K |
Kellanova |
Director |
• • – |
2023-05-08 |
4/A |
A |
$0.00 |
$0 |
I/I |
2,180 |
21,867 |
0 |
- |
|
| K |
Kellanova |
Director |
• • – |
2023-05-08 |
4 |
A |
$0.00 |
$0 |
I/I |
2,080 |
21,767 |
0 |
- |
|
| K |
Kellanova |
Director |
• • – |
2022-05-09 |
4 |
A |
$0.00 |
$0 |
I/I |
2,080 |
19,040 |
0 |
- |
|
| PG |
Procter & Gamble Co |
CEO - Health Care |
• • – |
2022-03-01 |
4 |
S |
$153.51 |
$572,597 |
D/D |
(3,730) |
28,156 |
0 |
% |
|
| PG |
Procter & Gamble Co |
CEO - Health Care |
• • – |
2021-12-06 |
4 |
D |
$148.83 |
$40,927 |
D/D |
(275) |
31,718 |
0 |
- |
|
| PG |
Procter & Gamble Co |
CEO - Health Care |
• • – |
2021-12-06 |
4 |
OE |
$148.83 |
$9,338 |
D/D |
63 |
31,993 |
0 |
- |
|
| PG |
Procter & Gamble Co |
CEO - Health Care |
• • – |
2021-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,251 |
31,748 |
0 |
- |
|
| PG |
Procter & Gamble Co |
CEO - Health Care |
• • – |
2021-08-19 |
4 |
S |
$143.90 |
$2,224,118 |
D/D |
(15,456) |
28,497 |
0 |
% |
|
| PG |
Procter & Gamble Co |
CEO - Health Care |
• • – |
2021-08-17 |
4 |
S |
$144.37 |
$1,832,934 |
D/D |
(12,696) |
43,953 |
0 |
% |
|
| PG |
Procter & Gamble Co |
CEO - Health Care |
• • – |
2021-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
28,152 |
56,649 |
0 |
- |
|
| PG |
Procter & Gamble Co |
CEO - Health Care |
• • – |
2021-08-02 |
4 |
S |
$141.77 |
$1,101,836 |
D/D |
(7,772) |
28,333 |
0 |
% |
|
| PG |
Procter & Gamble Co |
Group Pres-Chief Sales Officer |
• • – |
2021-05-26 |
4 |
S |
$138.20 |
$414,600 |
D/D |
(3,000) |
36,105 |
0 |
% |
|
| PG |
Procter & Gamble Co |
Group Pres-Chief Sales Officer |
• • – |
2021-05-11 |
4 |
S |
$137.27 |
$482,243 |
D/D |
(3,513) |
38,936 |
0 |
% |
|
| K |
Kellanova |
Director |
• • – |
2021-05-10 |
4 |
A |
$0.00 |
$0 |
I/I |
2,273 |
16,374 |
0 |
- |
|
| PG |
Procter & Gamble Co |
Group Pres-Chief Sales Officer |
• • – |
2021-02-26 |
4 |
S |
$125.77 |
$991,079 |
D/D |
(7,880) |
42,449 |
0 |
% |
|
| PG |
Procter & Gamble Co |
Group Pres-Chief Sales Officer |
• • – |
2020-12-15 |
4 |
D |
$136.85 |
$50,364 |
D/D |
(368) |
50,134 |
0 |
- |
|
| PG |
Procter & Gamble Co |
Group Pres-Chief Sales Officer |
• • – |
2020-12-15 |
4 |
OE |
$136.85 |
$9,220 |
D/D |
67 |
50,502 |
0 |
- |
|
| PG |
Procter & Gamble Co |
Group Pres-Chief Sales Officer |
• • – |
2020-11-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
700 |
50,260 |
0 |
- |
|
| PG |
Procter & Gamble Co |
Group Pres-Chief Sales Officer |
• • – |
2020-10-27 |
4 |
S |
$142.94 |
$7,413,744 |
D/D |
(51,867) |
50,960 |
0 |
% |
|
| PG |
Procter & Gamble Co |
Group Pres-Chief Sales Officer |
• • – |
2020-10-27 |
4 |
OE |
$69.45 |
$3,912,135 |
D/D |
51,867 |
81,331 |
0 |
- |
|
| PG |
Procter & Gamble Co |
Group Pres-Chief Sales Officer |
• • – |
2020-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,969 |
50,960 |
0 |
- |
|
| PG |
Procter & Gamble Co |
Group Pres-Chief Sales Officer |
• • – |
2020-08-19 |
4 |
S |
$136.00 |
$2,589,848 |
D/D |
(19,043) |
47,991 |
0 |
% |
|
| PG |
Procter & Gamble Co |
Group Pres-Chief Sales Officer |
• • – |
2020-08-18 |
4 |
S |
$136.53 |
$2,297,883 |
D/D |
(16,831) |
67,034 |
0 |
% |
|
| PG |
Procter & Gamble Co |
Group Pres-Chief Sales Officer |
• • – |
2020-08-18 |
4 |
A |
$0.00 |
$0 |
D/D |
35,874 |
83,865 |
0 |
- |
|
| PG |
Procter & Gamble Co |
Group Pres-Chief Sales Officer |
• • – |
2020-07-31 |
4 |
S |
$130.00 |
$1,224,080 |
D/D |
(9,416) |
47,824 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
